Med mindre fortsat ARB- behandling anses for at være essentiel, bør patienter, der planlægger graviditet, skiftes til alternative anithypertensive behandlinger, som har en etableret sikkerhedsprofil for anvendelse under graviditet.
Unless continued ARB therapy is considered essential, patients planning pregnancy should be changed to alternative anti- hypertensive treatments which have an established safety profile for use in pregnancy.